NCT03905564 - A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions | Biotech Hunter

Timeline

Start Date

June 30, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions

Bioavailability

Interventions

DRUG

doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg combination

Delayed-release tablet containing a fixed-dose combination of doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg (product of Tecnandina, S.A. TENSA).

DRUG

Diclegis (Registered Trademark)

Delayed-release tablet containing a fixed-dose combination of doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg (product of Duchesnay Inc.).